GeneChem Therapeutics Venture Fund

GeneChem is a Montreal-based venture capital firm specializing in the life sciences and biotechnology sectors. Founded in 1997, the firm manages several specialized funds, including the GeneChem Therapeutics Venture Fund, which focuses on early-stage investments in companies developing genomics-based therapies for cancer, infectious diseases, and metabolic disorders. GeneChem has been a pivotal player in the Canadian biotech ecosystem, bridging the gap between academic research and commercial drug development. The firm's portfolio includes over 60 companies across North America and Europe. In 2011, the principals of GeneChem launched AmorChem, a successor fund dedicated to seed-stage life science projects.